Abstract
Cutaneous adverse drug reactions (CADR) are the most common drug reactions in the pediatric population. Several aspects of CADR and other rashes are more unique to children and impact the diagnosis and management of CADRs in this population. Such factors include different age groups, each with unique features, concurrent viral/bacterial illnesses which could be associated with an exanthem and age-specific pharmacokinetics. The proportional dominance of offending drug classes is different than in adults—anti-infectives make the majority, followed by antipyretics and antiepileptics. In this chapter, unique CADR features in the pediatric population are discussed, and a morphologic approach, based on simple and complex/severe eruptions, is suggested.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ADR:
-
Adverse drug reactions
- AGEP:
-
Acute generalized exanthematous pustulosis
- cADR:
-
Cutaneous adverse drug reactions
- CPNDS:
-
Canadian pharmacogenomics network for drug safety
- DIHS:
-
Drug-induced hypersensitivity syndrome
- DRESS:
-
Drug reaction with eosinophilia and systemic symptoms
- EM:
-
Erythema multiforme
- GI:
-
Gastrointestinal
- JIA:
-
Juvenile idiopathic arthritis
- MIRM:
-
Mycoplasma-induced rash and mucositis
- NICUs:
-
Neonatal intensive care units
- NSAIDs:
-
Nonsteroidal anti-inflammatory drugs
- SJS/TEN:
-
Stevens–Johnson syndrome/toxic epidermal necrolysis
- SSLR:
-
Serum sickness-like reactions
References
Alerhand S, Cassella C, Koyfman A (2016) Stevens-Johnson syndrome and toxic epidermal necrolysis in the pediatric population: a review. Pediatr Emerg Care 32(7):472–476
Aljebab F, Choonara I, Conroy S (2017) Systematic review of the toxicity of long-course oral corticosteroids in children. PLoS One 12(1):e0170259. https://doi.org/10.1371/journal.pone.0170259 eCollection 2017
Anderson GD (2002) Children versus adults: pharmacokinetic and adverse-effect differences. Epilepsia 43(Suppl 3):53–59
Avner M, Finkelstein Y, Hackam D, Koren G (2007) Establishing causality in pediatric adverse drug reactions. Pediatr Drugs 9(4):267–270
Canavan TN, Mathes EF, Frieden I, Shinkai K (2015) Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review. J Am Acad Dermatol 72(2):239–245. https://doi.org/10.1016/j.jaad.2014.06.026
Castro-Pastrana LI, Ghannadan R, Rieder MJ, Dahlke E, Hayden M, Carleton B (2011) Cutaneous adverse drug reactions in children: an analysis of reports from the Canadian pharmacogenomics network for drug safety (CPNDS). J Popul Ther Clin Pharmacol 18:e106–e120
Catt CJ, Hamilton GM, Fish J, Mireskandari K, Ali A (2016) Ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Am J Ophthalmol 166:68–75. https://doi.org/10.1016/j.ajo.2016.03.020
Conroy S, Choonara I, Impicciatore P et al (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. European network for drug investigation in children. BMJ 320:79–82
De Silva B, Banney L, Uttley W, Luqmani R, Schofield O (2000) Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis. Pediatr Dermatol 17(6):480–483
Dibek Misirlioglu E, Guvenir H, Bahceci S, Haktanir Abul M, Can D, Usta Guc BE, Erkocoğlu M, Toyran M, Nacaroglu HT, Civelek E, Buyuktiryaki B, Ginis T, Orhan F, Kocabas CN (2017) Severe cutaneous adverse drug reactions in pediatric patients: a multicenter study. J Allergy Clin Immunol Pract 5:757. https://doi.org/10.1016/j.jaip.2017.02.013
Dilek N, Özkol HU, Akbaş A, Kılınç F, Dilek AR, Saral Y, Metin A, Çalka Ö (2014) Cutaneous drug reactions in children: a multicentric study. Postep Derm Alergol XXXI(6):368–371
Drago F, Paolino S, Rebora A, Broccolo F, Drago F, Cardo P, Parodi A (2012) The challenge of diagnosing atypical exanthems: a clinico-laboratory study original research article. J Am Acad Dermatol 67(6):1282–1288
Du W, Lehr VT, Lieh-Lai M, Koo W, Ward RM, Rieder MJ, Van Den Anker JN, Reeves JH, Mathew M, Lulic-Botica M, Aranda JV (2013) An algorithm to detect adverse drug reactions in the neonatal intensive care unit. J Clin Pharmacol 53(1):87–95. https://doi.org/10.1177/0091270011433327
Emer JJ, Bernardo SG, Kovalerchik O, Ahmad M (2013) Urticaria multiforme. J Clin Aesthet Dermatol 6(3):34–39
Ferrero NA, Pearson KC, Zedek DC et al (2013) Case report of drug rash with eosinophilia and systemic symptoms demonstrating human herpesvirus-6 reactivaion. Pediatr Dermatol 30(5):608–613
Finkelstein Y, Soon GS, Acuna P, George M, Pope E, Ito S, Shear NH, Koren G, Shannon MW, Garcia-Bournissen F (2011) Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Pediatrics 128(4):723–728
Food and Drug Administration (2001) The pediatric exclusivity provision: January 2001 status report to congress. Food and Drug Administration, Rockville, MD
Gul Mert G, Incecik F, Gunasti S, Herguner O, Altunbasak S (2013) Psoriasiform drug eruption associated with sodium valproate. Case Rep Pediatr 2013:823469
Heelan K, Shear NH (2013) Cutaneous drug reactions in children: an update. Pediatr Drugs 15:493–503
Hsu DY, Brieva J, Silverberg NB, Paller AS, Silverberg JI (2017) Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. J Am Acad Dermatol 76(5):811–817.e4. https://doi.org/10.1016/j.jaad.2016.12.024
Husain Z, Reddy BY, Schwartz RA (2013) DRESS syndrome: Part I Clinical perspectives. J Am Acad Dermatol 68(5):693.e1–693.14. https://doi.org/10.1016/j.jaad.2013.01.033; quiz 706–8.
Kardaun SH, Sekula P, Valeyrie-Allanore L et al (2013) Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 169(5):1071–1080
Kazandjieva J, Tsankov N (2017) Drug-induced acne. Clin Dermatol 35(2):156–162
Lansang P, Weinstein M, Shear N (2011) Drug reactions. In: Schachner LA, Hansen RC (eds) Pediatric dermatology, 4th edn. Mosby Elsevier, London, pp 1698–1711
Lewis AL, M. Klintworth E, O. Hinton J, M. Gray K (2013) Adolescent medication misuse: results from the MUSC inventory of medication experiences (MIME). Adolesc Psychiatry (Hilversum) 3(2):184–189
Lugo R, Ward R (2004) Basic pharmacokinetic principles. In: Polin R, Fox W, Abman S (eds) Fetal and neonatal physiology, 3rd edn. Harcourt Health Sciences, Philadelphia, pp 190–197
Macdonald JB, Macdonald B, Golitz LE, Lorusso P, Sekulic A (2015) Cutaneous adverse effects of targeted therapies. J Am Acad Dermatol 72(2):203–218, 221–236.
Moore TJ, Weiss SR, Kaplan S, Blaisdell CJ (2002) Reported adverse drug events in infants and children under 2 years of age. Pediatrics 110(5):e53
Morelli JG, Tay YK, Rogers M, Halbert A, Krafchik B, Weston WL (1999) Fixed drug eruptions in children. J Pediatr 134(3):365–367
Murray DL, Singer DA, Singer AB, Veldman JP (1980) Cefaclor--a cluster of adverse reactions. N Engl J Med 303(17):1003
Nacaroglu HT, Celegen M, Ozek G, Umac O, Karkıner CS, Yıldırım HT, Can D (2014) Acute generalized exanthematous pustulosis induced by ceftriaxone use. Postepy Dermatol Alergol 31(4):269–271
Noguera-Morel L, Hernández-Martín A, Torrelo A (2014) Cutaneous drug reactions in the pediatric population. Pediatr Clin N Am 61:403–426
Nussinovitch M, Prais D, Ben-Amitai D, Amir J, Volovitz B (2002) Fixed drug eruption in the genital area in 15 boys. Pediatr Dermatol 19(3):216–219
Okubo Y, Nochioka K, Testa MA (2017) Nationwide survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in children in the United States. Pediatr Dermatol 34(2):206–208. https://doi.org/10.1111/pde.13050
Ott H (2011) Chapter 183. Hypersensitivity reactions to drugs. In: Harper’s textbook of pediatric dermatology. Wiley Blackwell, Oxford
Pavlos R, Mallal S, Phillips E (2012) HLA and pharmacogenetics of drug hypersensitivity. Pharmacogenomics 13(11):1285–1306
Pichler WJ, Daubner B, Kawabata T (2011) Drug hypersensitivity: flare-up reactions, cross-reactivity and multiple drug hypersensitivity. J Dermatol 38(3):216–221. https://doi.org/10.1111/j.1346-8138.2010.01142.x
Posso-De Los Rios CJ, Pope E (2014) New insights into pustular dermatoses in pediatric patients. J Am Acad Dermatol 70(4):767–773
Rebelo Gomes E, Fonseca J, Araujo L, Demoly P (2008) Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy 38(1):191–198
Romiti R, Araujo KM, Steinwurz F, Denadai R (2016) Anti-tumor necrosis factor α-related psoriatic lesions in children with inflammatory bowel disease: case report and systematic literature review. Pediatr Dermatol 33(2):e174–e178
Sasidharanpillai S, Sabitha S, Riyaz N, Binitha MP, Muhammed K, Riyaz A, Jayakrishnan MP, Reyila VP (2016) Drug reaction with eosinophilia and systemic symptoms in children: a prospective study. Pediatr Dermatol 33(2):e162–e165. https://doi.org/10.1111/pde.12803
Sherlock ME, Walters T, Tabbers MM, Frost K, Zachos M, Muise A, Pope E, Griffiths AM (2013) Infliximab-induced psoriasis and psoriasiform skin lesions in pediatric Crohn disease and a potential association with IL-23 receptor polymorphisms. J Pediatr Gastroenterol Nutr 56(5):512–518
Smith WA, Siegel D, Lyon VB, Holland KE (2013) Psoriasiform eruption and oral ulcerations as adverse effects of topical 5% imiquimod treatment in children: a report of four cases. Pediatr Dermatol 30(6):e157–e160
Star K, Noren GN, Nordin K, Edwards IR (2011) Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase. Drug Saf 34(5):415–428
Statistics Canada 2013 http://www.statcan.gc.ca/pub/82-624-x/2013001/article/11879-eng.htm. Accessed 10 July 2017
t Jong GW, Vulto AG, de Hoog M et al (2000) Unapproved and off-label use of drugs in a children’s hospital. N Engl J Med 343:1125
Thompson DF, Ramos CL (2017) Antibiotic-induced rash in patients with infectious mononucleosis. Ann Pharmacother 51(2):154–162. https://doi.org/10.1177/1060028016669525
Tsakok T, Du Toit G, Flohr C (2014) Pediatric urticaria. Immunol Allergy Clin N Am 34(1):117–139. https://doi.org/10.1016/j.iac.2013.09.008
Van Batavia JP, Chu DI, Long CJ, Jen M, Canning DA, Weiss DA (2017) Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Pediatr Urol 13:490.e1. https://doi.org/10.1016/j.jpurol.2017.01.018
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Fridental, I., Finkelstein, Y. (2019). Cutaneous Adverse Drug Reactions in Pediatric Population. In: Shear, N., Dodiuk-Gad, R. (eds) Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions. Adis, Singapore. https://doi.org/10.1007/978-981-13-1489-6_11
Download citation
DOI: https://doi.org/10.1007/978-981-13-1489-6_11
Published:
Publisher Name: Adis, Singapore
Print ISBN: 978-981-13-1488-9
Online ISBN: 978-981-13-1489-6
eBook Packages: MedicineMedicine (R0)